Larry Biegelsen
Stock Analyst at Wells Fargo
(3.71)
# 722
Out of 4,955 analysts
330
Total ratings
53.19%
Success rate
5.82%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Overweight | $98 → $100 | $91.94 | +8.77% | 18 | Aug 20, 2025 | |
| HYPR Hyperfine | Maintains: Equal-Weight | $0.68 → $0.85 | $1.23 | -30.89% | 6 | Aug 15, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Equal-Weight | $20 → $13 | $11.01 | +18.07% | 10 | Aug 7, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $84 → $88 | $81.93 | +7.41% | 17 | Aug 7, 2025 | |
| ALC Alcon | Reinstates: Equal-Weight | $93 | $79.20 | +17.42% | 9 | Aug 6, 2025 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $174 → $101 | $93.51 | +8.01% | 13 | Aug 5, 2025 | |
| SYK Stryker | Maintains: Overweight | $435 → $445 | $387.15 | +14.94% | 16 | Aug 1, 2025 | |
| TFX Teleflex | Maintains: Equal-Weight | $137 → $131 | $126.50 | +3.56% | 6 | Aug 1, 2025 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $6 → $3 | $1.53 | +96.08% | 7 | Aug 1, 2025 | |
| BAX Baxter International | Maintains: Equal-Weight | $33 → $24 | $24.22 | -0.91% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $86 → $92 | $90.25 | +1.94% | 15 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $15 | $14.55 | +3.13% | 7 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $108 → $100 | $87.23 | +14.64% | 11 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $315 → $290 | $255.51 | +13.50% | 19 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $40 → $15 | $11.90 | +21.85% | 18 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $124 | $105.62 | +17.40% | 14 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $559 → $599 | $471.36 | +27.08% | 20 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $27 | $16.54 | +63.24% | 2 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $25 → $9 | $8.80 | +2.27% | 14 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $118 → $93 | $73.54 | +26.46% | 17 | May 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $113 → $98 | $105.21 | -6.85% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $89 | $73.85 | +20.51% | 4 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $8.69 | +95.74% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $166 → $152 | $179.70 | -15.41% | 13 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $90 → $94 | $81.18 | +15.79% | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $40 → $49 | $14.01 | +249.75% | 2 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $132.99 | +2.26% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $80 → $70 | $60.97 | +14.81% | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $198.40 | +36.09% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $58.95 | - | 2 | Nov 2, 2017 |
Medtronic
Aug 20, 2025
Maintains: Overweight
Price Target: $98 → $100
Current: $91.94
Upside: +8.77%
Hyperfine
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.23
Upside: -30.89%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $20 → $13
Current: $11.01
Upside: +18.07%
Edwards Lifesciences
Aug 7, 2025
Maintains: Overweight
Price Target: $84 → $88
Current: $81.93
Upside: +7.41%
Alcon
Aug 6, 2025
Reinstates: Equal-Weight
Price Target: $93
Current: $79.20
Upside: +17.42%
Inspire Medical Systems
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $174 → $101
Current: $93.51
Upside: +8.01%
Stryker
Aug 1, 2025
Maintains: Overweight
Price Target: $435 → $445
Current: $387.15
Upside: +14.94%
Teleflex
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $137 → $131
Current: $126.50
Upside: +3.56%
Pulmonx
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.53
Upside: +96.08%
Baxter International
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $24.22
Upside: -0.91%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $86 → $92
Current: $90.25
Upside: +1.94%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $14.55
Upside: +3.13%
Jul 31, 2025
Maintains: Overweight
Price Target: $108 → $100
Current: $87.23
Upside: +14.64%
Jul 30, 2025
Maintains: Overweight
Price Target: $315 → $290
Current: $255.51
Upside: +13.50%
Jul 25, 2025
Downgrades: Equal-Weight
Price Target: $40 → $15
Current: $11.90
Upside: +21.85%
Jul 24, 2025
Maintains: Overweight
Price Target: $118 → $124
Current: $105.62
Upside: +17.40%
Jul 23, 2025
Maintains: Overweight
Price Target: $559 → $599
Current: $471.36
Upside: +27.08%
Jul 17, 2025
Maintains: Overweight
Price Target: $28 → $27
Current: $16.54
Upside: +63.24%
Jul 9, 2025
Downgrades: Equal-Weight
Price Target: $25 → $9
Current: $8.80
Upside: +2.27%
May 30, 2025
Maintains: Overweight
Price Target: $118 → $93
Current: $73.54
Upside: +26.46%
May 6, 2025
Maintains: Equal-Weight
Price Target: $113 → $98
Current: $105.21
Upside: -6.85%
May 1, 2025
Maintains: Overweight
Price Target: $103 → $89
Current: $73.85
Upside: +20.51%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $8.69
Upside: +95.74%
Jan 23, 2025
Maintains: Equal-Weight
Price Target: $166 → $152
Current: $179.70
Upside: -15.41%
Dec 11, 2024
Maintains: Overweight
Price Target: $90 → $94
Current: $81.18
Upside: +15.79%
Dec 5, 2023
Upgrades: Overweight
Price Target: $40 → $49
Current: $14.01
Upside: +249.75%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $132.99
Upside: +2.26%
May 11, 2022
Maintains: Overweight
Price Target: $80 → $70
Current: $60.97
Upside: +14.81%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $198.40
Upside: +36.09%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $58.95
Upside: -